Long-term survival on peritoneal dialysis is not a dream anymore: Lessons from the East

Peritoneal Dialysis International

Volumn 27, Issue 4, 2007, Pages 410-412

  Oreopoulos, Dimitrios G ^a   Yang, Xiao ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CA 125 ANTIGEN; DIALYSIS FLUID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENTAMICIN; ICODEXTRIN; PSEUDOMONIC ACID;

AGE DISTRIBUTION; BIOCOMPATIBILITY; CATHETER INFECTION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ENCAPSULATING PERITONEAL SCLEROSIS; EVIDENCE BASED MEDICINE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; NOTE; OUTCOMES RESEARCH; PATIENT SELECTION; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL FIBROSIS; PERITONITIS; PRIORITY JOURNAL; RENAL PROTECTION; RISK BENEFIT ANALYSIS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 34547644307     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700407     Document Type: Note

References (27)

1. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 2007; 49(1 Suppl 1):A6-7, S1-296.
2. Mehrotra R. Peritoneal dialysis penetration in the United States: march toward the fringes? Perit Dial Int 2006; 26: 419-22.
3. Lameire N, Peeters P, Vanholder R, Van Biesen W. Peritoneal dialysis in Europe: an analysis of its rise and fall Blood Purif 2006; 24:107-14.
4. Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot C, et al. The Renal Epidemiology and Information Network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21: 411-18.
5. Bender FH, Bernardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 2006; 70(1 Suppl 1): S44-54.
6. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int 2007; 27: 432-40.
7. Blake PG. Peritoneal dialysis in Asia: an external perspective. Perit Dial Int 2002; 22:258-64.
8. Chan MK, Lam SS, Chan PC, Cheng IK. Continuous ambulatory peritoneal dialysis (CAPD): experience with the first 100 patients in a Hong Kong centre. Int J Artif Organs 1987; 10:77-82.
9. Kawaguchi Y. National comparisons: optimal peritoneal dialysis outcomes among Japanese patients. Perit Dial Int 1999; 19(Suppl 3):S9-16.
10. Wang AY. The "heart" of peritoneal dialysis: residual renal function. Perit Dial Int 2007; 27:116-24.
11. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158-62.
12. Shoda J, Kanno Y, Suzuki H. A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Intern Med 2006; 45: 193-8.
13. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 2003; 139: 105-12.
14. Woodrow G. A randomized controlled trial to determine whether treatment with a neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients. Perit Dial Int 2006; 26:113-14.
15. Lobbedez T, Gardam M, Dedier H, Burdzy D, Chu M, Izatt S, et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004; 19:3140-3.
16. Prakashan KP, Annigeri RA, Chu M, Bargman JM, Vas SI, Oreopoulos DG. Local application of mupirocin at the peritoneal catheter exit site prevents early postoperative infections and should become standard practice. Perit Dial Int 2001; 21:526-7.
17. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
18. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT; Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88:S43-9.
19. Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis 2006; 47:697-712.
20. Ahmad M, Shah H, Pliakogiannis T, Oreopoulos DG. Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions. Int Urol Nephrol 2007; 39:299-312.
21. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al; Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
22. Garcia H, Hernandez-Jaras J, del Carmen Cruz M, Agramunt I, Calvo C, Cerrillo V. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution. Perit Dial Int 2003; 23:375-80.
23. Lee HY, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, et al. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 2006; 21:2893-9.
24. Bargman JM. Peritoneal dialysis solutions and patient survival: does wishing make it so? Nephrol Dial Transplant 2006; 21:2684-6.
25. Davies SJ. Exploring new evidence of the clinical benefits of icodextrin solutions. Nephrol Dial Transplant 2006; 21(Suppl 2):ii47-50.
26. Charest AF, Mendelssohn DC. Are North American nephrologists biased against peritoneal dialysis? Perit Dial Int 2001; 21:335-7.
27. Jassal SV, Krishna G, Mallick NP, Mendelssohn DC. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant 2002; 17:474-7.